The global Biodefense market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals
By Types:
Anthrax
Smallpox
Botulism
Radiation/Nuclear
Others
By Applications:
US Military Market
US Civilian Market
Non - US Market
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Biodefense Market Size Analysis from 2023 to 2028
1.5.1 Global Biodefense Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Biodefense Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Biodefense Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Biodefense Industry Impact
Chapter 2 Global Biodefense Competition by Types, Applications, and Top Regions and Countries
2.1 Global Biodefense (Volume and Value) by Type
2.1.1 Global Biodefense Consumption and Market Share by Type (2017-2022)
2.1.2 Global Biodefense Revenue and Market Share by Type (2017-2022)
2.2 Global Biodefense (Volume and Value) by Application
2.2.1 Global Biodefense Consumption and Market Share by Application (2017-2022)
2.2.2 Global Biodefense Revenue and Market Share by Application (2017-2022)
2.3 Global Biodefense (Volume and Value) by Regions
2.3.1 Global Biodefense Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Biodefense Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Biodefense Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Biodefense Consumption by Regions (2017-2022)
4.2 North America Biodefense Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Biodefense Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Biodefense Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Biodefense Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Biodefense Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Biodefense Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Biodefense Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Biodefense Sales, Consumption, Export, Import (2017-2022)
4.10 South America Biodefense Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Biodefense Market Analysis
5.1 North America Biodefense Consumption and Value Analysis
5.1.1 North America Biodefense Market Under COVID-19
5.2 North America Biodefense Consumption Volume by Types
5.3 North America Biodefense Consumption Structure by Application
5.4 North America Biodefense Consumption by Top Countries
5.4.1 United States Biodefense Consumption Volume from 2017 to 2022
5.4.2 Canada Biodefense Consumption Volume from 2017 to 2022
5.4.3 Mexico Biodefense Consumption Volume from 2017 to 2022
Chapter 6 East Asia Biodefense Market Analysis
6.1 East Asia Biodefense Consumption and Value Analysis
6.1.1 East Asia Biodefense Market Under COVID-19
6.2 East Asia Biodefense Consumption Volume by Types
6.3 East Asia Biodefense Consumption Structure by Application
6.4 East Asia Biodefense Consumption by Top Countries
6.4.1 China Biodefense Consumption Volume from 2017 to 2022
6.4.2 Japan Biodefense Consumption Volume from 2017 to 2022
6.4.3 South Korea Biodefense Consumption Volume from 2017 to 2022
Chapter 7 Europe Biodefense Market Analysis
7.1 Europe Biodefense Consumption and Value Analysis
7.1.1 Europe Biodefense Market Under COVID-19
7.2 Europe Biodefense Consumption Volume by Types
7.3 Europe Biodefense Consumption Structure by Application
7.4 Europe Biodefense Consumption by Top Countries
7.4.1 Germany Biodefense Consumption Volume from 2017 to 2022
7.4.2 UK Biodefense Consumption Volume from 2017 to 2022
7.4.3 France Biodefense Consumption Volume from 2017 to 2022
7.4.4 Italy Biodefense Consumption Volume from 2017 to 2022
7.4.5 Russia Biodefense Consumption Volume from 2017 to 2022
7.4.6 Spain Biodefense Consumption Volume from 2017 to 2022
7.4.7 Netherlands Biodefense Consumption Volume from 2017 to 2022
7.4.8 Switzerland Biodefense Consumption Volume from 2017 to 2022
7.4.9 Poland Biodefense Consumption Volume from 2017 to 2022
Chapter 8 South Asia Biodefense Market Analysis
8.1 South Asia Biodefense Consumption and Value Analysis
8.1.1 South Asia Biodefense Market Under COVID-19
8.2 South Asia Biodefense Consumption Volume by Types
8.3 South Asia Biodefense Consumption Structure by Application
8.4 South Asia Biodefense Consumption by Top Countries
8.4.1 India Biodefense Consumption Volume from 2017 to 2022
8.4.2 Pakistan Biodefense Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Biodefense Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Biodefense Market Analysis
9.1 Southeast Asia Biodefense Consumption and Value Analysis
9.1.1 Southeast Asia Biodefense Market Under COVID-19
9.2 Southeast Asia Biodefense Consumption Volume by Types
9.3 Southeast Asia Biodefense Consumption Structure by Application
9.4 Southeast Asia Biodefense Consumption by Top Countries
9.4.1 Indonesia Biodefense Consumption Volume from 2017 to 2022
9.4.2 Thailand Biodefense Consumption Volume from 2017 to 2022
9.4.3 Singapore Biodefense Consumption Volume from 2017 to 2022
9.4.4 Malaysia Biodefense Consumption Volume from 2017 to 2022
9.4.5 Philippines Biodefense Consumption Volume from 2017 to 2022
9.4.6 Vietnam Biodefense Consumption Volume from 2017 to 2022
9.4.7 Myanmar Biodefense Consumption Volume from 2017 to 2022
Chapter 10 Middle East Biodefense Market Analysis
10.1 Middle East Biodefense Consumption and Value Analysis
10.1.1 Middle East Biodefense Market Under COVID-19
10.2 Middle East Biodefense Consumption Volume by Types
10.3 Middle East Biodefense Consumption Structure by Application
10.4 Middle East Biodefense Consumption by Top Countries
10.4.1 Turkey Biodefense Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Biodefense Consumption Volume from 2017 to 2022
10.4.3 Iran Biodefense Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Biodefense Consumption Volume from 2017 to 2022
10.4.5 Israel Biodefense Consumption Volume from 2017 to 2022
10.4.6 Iraq Biodefense Consumption Volume from 2017 to 2022
10.4.7 Qatar Biodefense Consumption Volume from 2017 to 2022
10.4.8 Kuwait Biodefense Consumption Volume from 2017 to 2022
10.4.9 Oman Biodefense Consumption Volume from 2017 to 2022
Chapter 11 Africa Biodefense Market Analysis
11.1 Africa Biodefense Consumption and Value Analysis
11.1.1 Africa Biodefense Market Under COVID-19
11.2 Africa Biodefense Consumption Volume by Types
11.3 Africa Biodefense Consumption Structure by Application
11.4 Africa Biodefense Consumption by Top Countries
11.4.1 Nigeria Biodefense Consumption Volume from 2017 to 2022
11.4.2 South Africa Biodefense Consumption Volume from 2017 to 2022
11.4.3 Egypt Biodefense Consumption Volume from 2017 to 2022
11.4.4 Algeria Biodefense Consumption Volume from 2017 to 2022
11.4.5 Morocco Biodefense Consumption Volume from 2017 to 2022
Chapter 12 Oceania Biodefense Market Analysis
12.1 Oceania Biodefense Consumption and Value Analysis
12.2 Oceania Biodefense Consumption Volume by Types
12.3 Oceania Biodefense Consumption Structure by Application
12.4 Oceania Biodefense Consumption by Top Countries
12.4.1 Australia Biodefense Consumption Volume from 2017 to 2022
12.4.2 New Zealand Biodefense Consumption Volume from 2017 to 2022
Chapter 13 South America Biodefense Market Analysis
13.1 South America Biodefense Consumption and Value Analysis
13.1.1 South America Biodefense Market Under COVID-19
13.2 South America Biodefense Consumption Volume by Types
13.3 South America Biodefense Consumption Structure by Application
13.4 South America Biodefense Consumption Volume by Major Countries
13.4.1 Brazil Biodefense Consumption Volume from 2017 to 2022
13.4.2 Argentina Biodefense Consumption Volume from 2017 to 2022
13.4.3 Columbia Biodefense Consumption Volume from 2017 to 2022
13.4.4 Chile Biodefense Consumption Volume from 2017 to 2022
13.4.5 Venezuela Biodefense Consumption Volume from 2017 to 2022
13.4.6 Peru Biodefense Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Biodefense Consumption Volume from 2017 to 2022
13.4.8 Ecuador Biodefense Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Biodefense Business
14.1 Emergent Biosolutions
14.1.1 Emergent Biosolutions Company Profile
14.1.2 Emergent Biosolutions Biodefense Product Specification
14.1.3 Emergent Biosolutions Biodefense Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Hytest
14.2.1 Hytest Company Profile
14.2.2 Hytest Biodefense Product Specification
14.2.3 Hytest Biodefense Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 GSK
14.3.1 GSK Company Profile
14.3.2 GSK Biodefense Product Specification
14.3.3 GSK Biodefense Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Sanofi
14.4.1 Sanofi Company Profile
14.4.2 Sanofi Biodefense Product Specification
14.4.3 Sanofi Biodefense Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 PharmAthene
14.5.1 PharmAthene Company Profile
14.5.2 PharmAthene Biodefense Product Specification
14.5.3 PharmAthene Biodefense Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Bavarian Nordic
14.6.1 Bavarian Nordic Company Profile
14.6.2 Bavarian Nordic Biodefense Product Specification
14.6.3 Bavarian Nordic Biodefense Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 SIGA Technologies
14.7.1 SIGA Technologies Company Profile
14.7.2 SIGA Technologies Biodefense Product Specification
14.7.3 SIGA Technologies Biodefense Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Arbutus Biopharma
14.8.1 Arbutus Biopharma Company Profile
14.8.2 Arbutus Biopharma Biodefense Product Specification
14.8.3 Arbutus Biopharma Biodefense Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 DynPort Vaccine
14.9.1 DynPort Vaccine Company Profile
14.9.2 DynPort Vaccine Biodefense Product Specification
14.9.3 DynPort Vaccine Biodefense Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Xoma Corporation
14.10.1 Xoma Corporation Company Profile
14.10.2 Xoma Corporation Biodefense Product Specification
14.10.3 Xoma Corporation Biodefense Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Ichor Medical Systems
14.11.1 Ichor Medical Systems Company Profile
14.11.2 Ichor Medical Systems Biodefense Product Specification
14.11.3 Ichor Medical Systems Biodefense Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Aeolus Pharmaceuticals
14.12.1 Aeolus Pharmaceuticals Company Profile
14.12.2 Aeolus Pharmaceuticals Biodefense Product Specification
14.12.3 Aeolus Pharmaceuticals Biodefense Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 Achaogen
14.13.1 Achaogen Company Profile
14.13.2 Achaogen Biodefense Product Specification
14.13.3 Achaogen Biodefense Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 Elusys Therapeutics
14.14.1 Elusys Therapeutics Company Profile
14.14.2 Elusys Therapeutics Biodefense Product Specification
14.14.3 Elusys Therapeutics Biodefense Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.15 Dynavax Technologies
14.15.1 Dynavax Technologies Company Profile
14.15.2 Dynavax Technologies Biodefense Product Specification
14.15.3 Dynavax Technologies Biodefense Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.16 Cleveland BioLabs
14.16.1 Cleveland BioLabs Company Profile
14.16.2 Cleveland BioLabs Biodefense Product Specification
14.16.3 Cleveland BioLabs Biodefense Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.17 Soligenix
14.17.1 Soligenix Company Profile
14.17.2 Soligenix Biodefense Product Specification
14.17.3 Soligenix Biodefense Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.18 Alnylam Pharmaceuticals
14.18.1 Alnylam Pharmaceuticals Company Profile
14.18.2 Alnylam Pharmaceuticals Biodefense Product Specification
14.18.3 Alnylam Pharmaceuticals Biodefense Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Biodefense Market Forecast (2023-2028)
15.1 Global Biodefense Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Biodefense Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Biodefense Value and Growth Rate Forecast (2023-2028)
15.2 Global Biodefense Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Biodefense Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Biodefense Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Biodefense Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Biodefense Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Biodefense Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Biodefense Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Biodefense Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Biodefense Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Biodefense Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Biodefense Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Biodefense Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Biodefense Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Biodefense Consumption Forecast by Type (2023-2028)
15.3.2 Global Biodefense Revenue Forecast by Type (2023-2028)
15.3.3 Global Biodefense Price Forecast by Type (2023-2028)
15.4 Global Biodefense Consumption Volume Forecast by Application (2023-2028)
15.5 Biodefense Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
| Price : US$ 3500 |
Date : Apr 2024 |
| Category : Electronics |
Pages : 129 |
| Price : US$ 2450 |
Date : Apr 2024 |
| Category : Electronics |
Pages : 269 |
| Price : US$ 2450 |
Date : Feb 2024 |
| Category : Electronics |
Pages : 261 |
Request Sample 
Request Discount 
Inquire Before Buy
